Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Titel:
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Auteur:
Italiano, Antoine Soria, Jean-Charles Toulmonde, Maud Michot, Jean-Marie Lucchesi, Carlo Varga, Andrea Coindre, Jean-Michel Blakemore, Stephen J Clawson, Alicia Suttle, Benjamin McDonald, Alice A Woodruff, Mark Ribich, Scott Hedrick, Eric Keilhack, Heike Thomson, Blythe Owa, Takashi Copeland, Robert A Ho, Peter T C Ribrag, Vincent